A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma

计划入组 486 人 · 首次发布于 2025 年 5 月 1 日

Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers

计划入组 10 人 · 首次发布于 2020 年 2 月 5 日

Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study

计划入组 30 人 · 首次发布于 2026 年 7 月 24 日

P44-L

CT-P24

CT-P63/CT-P66

Nuvance Health Medical Practice CT, Inc.

United States

SpringWorks Therapeutics

United States

BioXcel Therapeutics

United States

Celltrion Advances Darzalex Biosimilar CT-P44 with FDA and EMA Phase 3 Trial Approvals

PSMA PET/CT Shows Similar Bone Metastasis Detection to Bone Scan in Prostate Cancer

Equivalence Confirmed: CT-P41 Paves the Way for Affordable Osteoporosis Care